IRE produces first batch of LEU-based Mo-99

May 6, 2020, 8:51AMNuclear News

Belgium’s National Institute of Radioelements (IRE) announced on April 30 that it has produced its first batch of commercial molybdenum-99 from low-enriched uranium (LEU) targets. The first batch of Mo-99, whose decay product, technetium-99m, is used in nuclear medicine for diagnostic imaging, was produced for the U.S. health market. IRE said that the conversion to LEU represents a key milestone for the institute in the global commitment to end the civilian use of highly enriched uranium (HEU) for the production of Mo-99.

To continue reading, log in or create a free account!

Related Articles

Atoms: Get more from your fuel

September 27, 2023, 5:57AMNuclear News

From the pages of the September 2023 issue of Nuclear News.For decades, more energy has meant more fuel: fossil fuels.But nuclear fuel—unlike coal, oil, or even natural uranium—is a feat...

Two new webinars recently hosted by ANS

July 11, 2023, 9:30AMANS News

Really taking off during the pandemic, ANS’s online event programming remains very strong and continues to be a great resource for the nuclear community. This year alone, ANS has produced 14...

Looking back and looking ahead

July 10, 2023, 9:30AMNuclear News

It is a great time to be American Nuclear Society president. There are very positive articles in Nuclear News and other places on the advances in fusion, nuclear in space, isotopes, and new...